Scholars requires JavaScript. Please enable it in your browser to view this page.
Skip to main content
Scholars
Beta
Weill Cornell Medicine
Browse
About
Sign in
Loading co-authored publications…
Feedback
Scholars
/
Ari M. Melnick, MD
/
Co-authored with Rebecca Goldstein
Co-authored publications
Ari M. Melnick, MD and Rebecca Goldstein · 4 publications
CSV
Word
EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis.
Cancer cell
· 2016
AM
Ari M. Melnick
RL
Rebecca L Goldstein
WB
Wendy Béguelin
MT
Matt Teater
MT
María Teresa Calvo Fernández
+5 more →
PMID:
27505670
·
PMCID:
PMC5000552
·
DOI
·
212 citations
·
Abstract
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.
The Journal of clinical investigation
· 2016
AM
Ari M. Melnick
RL
Rebecca L Goldstein
WB
Wendy Beguelin
MR
Matthew R Teater
KH
Katerina Hatzi
+4 more →
PMID:
27482887
·
PMCID:
PMC5004937
·
DOI
·
153 citations
·
Abstract
Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas.
Blood
· 2015
AM
Ari M. Melnick
RL
Rebecca L Goldstein
TM
Tharu M Fernando
RM
Rossella Marullo
+4 more →
LC
Leandro Cerchietti
PMID:
26603836
·
PMCID:
PMC4760090
·
DOI
·
77 citations
·
Abstract
Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphoma.
The Journal of clinical investigation
· 2015
AM
Ari M. Melnick
RL
Rebecca L Goldstein
KS
Kojo Seys John Elenitoba-Johnson
WT
Wayne Tam
JP
John P Leonard
+2 more →
PMID:
26529251
·
PMCID:
PMC4665772
·
DOI
·
41 citations
·
Abstract